NovaBridge Biosciences American Depositary Shares
NBP
132 hedge funds and large institutions have $1.83B invested in NovaBridge Biosciences American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 53 increasing their positions, 39 reducing their positions, and 33 closing their positions.
36% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 39
35% more call options, than puts
Call options by funds: $1.64M | Put options by funds: $1.22M
25% more funds holding in top 10
Funds holding in top 10: 8 → 10 (+2)
1.42% more ownership
Funds ownership: 20.37% → 21.79% (+1.4%)
8% less funds holding
Funds holding: 144 → 132 (-12)
30% less capital invested
Capital invested by funds: $2.61B → $1.83B (-$783M)
30% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 33
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$148M |
| 2 |
BlackRock
New York
|
+$34.3M |
| 3 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$18.2M |
| 4 |
OCA
Octagon Capital Advisors
New York
|
+$17.1M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$13.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$32.9M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$28.3M |
| 3 |
BS
Banco Santander
Madrid,
Spain
|
-$22.5M |
| 4 |
ZAM
Zeal Asset Management
Central,
Hong Kong
|
-$19M |
| 5 |
CCM
CAAS Capital Management
New York
|
-$18.4M |
NBP Hedge Fund Activity: Q4 2021 in Review
132 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q4 2021, worth a combined $1.83B — down 30% from $2.61B a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of NBP and 23 opened new positions — a net loss of 10 holders — while 39 trimmed existing stakes and 53 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $148M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $32.9M sold.
- 132 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q4 2021, down from 144 in Q3 2021.
- Funds reported $1.83B of NovaBridge Biosciences American Depositary Shares stock for Q4 2021, down 30% quarter-over-quarter.
- 23 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q4 2021 and 33 closed out, a net change of -10 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q4 2021 was T. Rowe Price Associates, an estimated $148M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q4 2021 was Avidity Partners Management, an estimated $32.9M sold.
Based on aggregated 13F filings for Q4 2021.